NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/02/2026
Voltar para busca
Dado oficial do USPTO
TARGETINGONE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
TARGETINGONE
ST13
US500000079343943Classe
5, 9, 10
Pedido
79343943
Registro
7601773
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
13/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
02/04/2022
Data de registro
17/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/12/2024
Última transação
13/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
CN
Examinador
CORDOVA, RAUL
Unidade examinadora
M50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
T. C. (pessoa física)
Representantes
NAZLY AILEEN BAYRAMOGLU BAYRAMOGLU LAW OFFICES LLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Chemical reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; chemical reagents used for rapid extraction of nucleic acids from biological samples; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectionfor detecting and treating infectious diseaseshereditary diseasesleukemiacancer; diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions; medical diagnostic test strips for blood analysisurine analysissaliva analysis; salts for medical purposes; preparations of microorganisms for medical purposes; biological preparations for the treatment of cancer; diagnostic preparations for medical purposes
Classe 9
Measuring apparatuselectronic devices used for the qualitative measurement of virus neutralizing antibodies in human serumplasma and whole blood for laboratory or research purposes; scientific apparatuspolymerase chain reaction (PCR) analyzer for measuring relative DNARNA and protein; scientific apparatus and instruments for measuring relative DNARNA and protein and parts and fittings therefor; surveying apparatus; surveying instruments; precision measuring apparatuselectronic devices used for the qualitative measurement of virus neutralizing antibodies in human serumplasma and whole blood for laboratory or research purposes; measuring instrumentselectronic devices used for the qualitative measurement of virus neutralizing antibodies in human serumplasma and whole blood for laboratory or research purposes; computer software applicationsdownloadablefor use in medical diagnostic fields; downloadable computer software for application and database integration; diagnostic apparatus for the detection of pathogens for laboratory or research use; medical laboratory research instruments for detecting pathogens and DNA analysis; optical inspection apparatus; sample preparation devices for laboratory or research purposes; scientific apparatus and instruments for extractingpurifying and separating nucleic acid for laboratory or research purposes; technical measuring and testing apparatus and instruments for measuringtesting and checking the temperaturepressurequantity and concentration of gas and liquids; polymerase chain reaction (PCR) testing apparatus for laboratory or research purpose
Classe 10
Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; sample preparation device for medical diagnostic use; medical apparatus used for rapid extractionpurification and separation of nucleic acid from samples; polymerase chain reaction (PCR) analyzing apparatus for medical purposes; medical diagnostic instruments for the analysis of body fluids; polymerase chain reaction (PCR) testing apparatus for medical purposes; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; blood testing apparatus; inhalers for medical use; insufflators for medical use; cases fitted for medical instruments; surgical apparatus and instruments; probes for medical purposes; medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for detecting cancer; medical diagnostic apparatus for testing cancer cells and DNAincorporating recorded operating system software
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/06/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/05/2025
FIMP
FINAL DISPOSITION PROCESSED
19/05/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2024
TMBN
TTAB RELEASE CASE TO TRADEMARKS
22/11/2024
OP.T
OPPOSITION TERMINATED NO. 999999
22/11/2024
OP.S
OPPOSITION SUSTAINED NO. 999999
22/11/2024
RFNP
REFUSAL PROCESSED BY IB
20/09/2024
OP.I
OPPOSITION INSTITUTED NO. 999999
23/08/2024
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
22/08/2024
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
22/08/2024
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
21/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/08/2024
PUBO
PUBLISHED FOR OPPOSITION
20/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2024
ALIE
ASSIGNED TO LIE
09/07/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/07/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/07/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/07/2024
RFNP
REFUSAL PROCESSED BY IB
22/01/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/12/2023
GNRT
NON-FINAL ACTION E-MAILED
15/12/2023
CNRT
NON-FINAL ACTION WRITTEN
15/12/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/12/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/12/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/09/2023
RFNT
REFUSAL PROCESSED BY IB
13/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/03/2023
RFRR
REFUSAL PROCESSED BY MPU
23/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/01/2023
CNRT
NON-FINAL ACTION WRITTEN
27/01/2023
DOCK
ASSIGNED TO EXAMINER
19/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TARGETINGONE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.